Clinical Trials
11 trialsNCT06222203 2026-06-04
Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
National Institutes of Health Clinical Center (CC)
Recruiting
NCT02544022 2026-06-01
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
National Institutes of Health Clinical Center (CC)
Recruiting
NCT06360406 2026-06-01
Real-World Treatment Study of Koselugo (Selumetinib)
AstraZeneca
Recruiting
NCT06880991 2026-04-29
Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study
National Institutes of Health Clinical Center (CC)
Recruiting
NCT03050268 2026-04-23
SJFAMILY
St. Jude Children's Research Hospital
Recruiting
NCT07221331 2026-04-16
PRECIOUS Egypt
AstraZeneca
Recruiting
NCT05954416 2026-02-12
FARD
Institut National de la Santé Et de la Recherche Médicale, France
Recruiting
NCT06515860 2026-01-09
NF1-TED
Boston Children's Hospital
Recruiting
NCT04395495 2025-12-18
RASopathy Biorepository
Children's Hospital Medical Center, Cincinnati
Recruiting
NCT06523582 2024-07-26
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Universidad Nacional Autonoma de Mexico
Recruiting
NCT01885767 2023-08-30
Neurofibromatosis (NF) Registry Portal
The Children's Tumor Foundation
Recruiting